Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

VU-0453595 shows potential for schizophrenia in a mouse model

Nov. 20, 2014

Investigators develop DNA-based vaccine against Leishmaniasis infection

Nov. 19, 2014

Preclinical pharmacology, safety and activity profiling of dual JAK3/ITK inhibitor ARN-4079

Nov. 19, 2014

P-11520031, a novel T-type calcium channel blocker for neuropathic pain

Nov. 19, 2014

RALDH 1 explored as a target for treating obesity and diabetes

Nov. 19, 2014

First possible biomarker for liver disease in alpha-1 antitypsin deficiency identified

Nov. 19, 2014

Validation of the antifibrogenic activity of a peripherally restricted CB1 antagonist

Nov. 19, 2014

Tumor antigen-targeted IL-15 complex eliminates lymphoma cells

Nov. 18, 2014

Genetic variant linked to intracranial major artery stenosis/occlusion

Nov. 18, 2014

Phase I results of a tetravalent purified inactivated dengue vaccine

Nov. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026